+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biomaterials in Spinal Implants Market by Product Type, Material Type, Application, End User - Global Forecast to 2030- Product Image
Biomaterials in Spinal Implants Market by Product Type, Material Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Biomaterials in Spinal Implants Market by Product Type, Material Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6085132
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Shaping the Future of Spinal Care through Biomaterial Innovation

Advanced biomaterials have emerged as the cornerstone of next-generation spinal implant therapies, driving unprecedented improvements in patient outcomes and redefining clinical protocols. This executive summary synthesizes the most pivotal trends, regulatory shifts, segmentation dynamics, and competitive strategies that are shaping the trajectory of the spinal implants market. Delving into innovations such as bioresorbable polymers, surface-modified titanium alloys, and additive manufacturing techniques, the analysis examines how these advancements are enabling enhanced osseointegration, reduced implant failure, and accelerated patient recovery.

Our assessment navigates the complexities introduced by evolving trade policies, particularly the United States tariff adjustments scheduled for 2025, and offers critical perspectives on supply chain resilience and cost management. The segmentation framework encompasses product types ranging from disc replacement devices to spinal fusion instruments, material technologies spanning from PEEK polymers to zirconia ceramics, clinical applications across degenerative and traumatic conditions, and end-user distributions among ambulatory surgery centers, hospital systems, and orthopedic clinics. Complementing these insights are in-depth regional analyses across the Americas, Europe Middle East & Africa, and Asia-Pacific, as well as profiles of leading market participants and strategic imperatives for industry leadership.

Emerging Technologies Redefining Spinal Implant Therapies

The landscape of spinal implant technology has undergone a profound transformation, propelled by the confluence of advanced manufacturing, bioactive surface chemistries, and data-driven device design. Additive manufacturing methods have unlocked unparalleled geometries that mimic trabecular bone architecture, while coatings infused with growth factors and antimicrobial agents are elevating long-term implant stability and infection resistance. Concurrently, composite materials that blend the mechanical strength of carbon fiber reinforcements with the biocompatibility of polymer matrices are gaining traction in load-bearing applications, reducing the risk of stress shielding and enhancing physiological load distribution.

In parallel, digital workflows empowered by computer-assisted surgical planning and intraoperative navigation systems are streamlining implant customization, minimizing operative times, and improving patient-specific outcomes. These interconnected shifts are not merely incremental; they represent a recalibration of the entire value chain, from research laboratories to operating rooms. Manufacturers that embrace a holistic approach-integrating material science breakthroughs, digital health platforms, and value-based clinical evidence-are best positioned to lead the next wave of growth.

Navigating Regulatory Pressures and Tariff Implications

Antecedent to 2025, the imposition of additional tariffs on imported raw materials and finished spinal implant components is set to introduce multifaceted cost pressures for both domestic and international stakeholders. Elevated duties on high-performance polymers such as PEEK, along with critical metal alloys including titanium, cobalt chromium, and stainless steel, will necessitate strategic realignments across global supply chains. Manufacturers are likely to respond by localizing select production activities, pursuing alternative sourcing arrangements, or renegotiating long-term supplier contracts to mitigate margin erosion.

Beyond the immediate cost implications, these tariff changes will amplify the importance of efficiency gains achieved through lean manufacturing processes and just-in-time inventory management. In parallel, the potential for pass-through pricing to end-users, including hospitals and ambulatory surgery centers, poses a risk of dampening device utilization rates unless offset by demonstrable clinical and economic value. As such, stakeholders must proactively engage in supply chain diversification strategies, foster domestic partnerships for material fabrication, and intensify value-based evidence generation to uphold competitive positioning in the face of shifting trade landscapes.

Comprehensive Segmentation Reveals Diverse Growth Paths

A multidimensional segmentation framework uncovers diverse growth trajectories and competitive arenas within the spinal implants sector. Based on product type, the market encompasses disc replacement devices distinguished by fixed bearing and mobile bearing mechanisms, interbody cages available in composite, PEEK, and titanium variants, pedicle screws offered as monoaxial and polyaxial configurations, rods and plates in both precontoured and straight geometries, as well as spinal fusion devices that facilitate vertebral stability. Material classifications span ceramic formulations such as alumina and zirconia, calcium phosphate bioactive ceramics, carbon fiber reinforced composites, cobalt chromium alloys, PEEK polymers, polymer matrix composites, stainless steel, titanium and its alloys, and ultra-high-molecular-weight polyethylene.

Clinically, applications range from degenerative disc disease to spinal deformities-including kyphosis and scoliosis-traumatic presentations such as dislocations and fractures, and tumor resections requiring reconstructive interventions. End-user channels comprise ambulatory surgery centers, hospital systems subdivided into government and private institutions, and specialized orthopedic clinics. By interlacing these segmentation layers, the analysis illuminates pockets of unmet clinical need, emerging preferences for minimally invasive solutions, and the strategic importance of aligning product portfolios with the nuanced demands of each therapeutic and care-delivery setting.

Regional Dynamics Shaping Global Market Penetration

Global and regional market drivers exhibit pronounced variability that shapes adoption rates and competitive dynamics across geographic corridors. In the Americas, advanced healthcare infrastructure, robust reimbursement frameworks, and high procedural volumes foster rapid uptake of innovative spinal implant solutions. North American players leverage strong clinical trial networks to substantiate product efficacy, while Latin American markets are witnessing incremental investments in surgical capacity and materials procurement.

Within the Europe Middle East & Africa sphere, regulatory harmonization efforts under the Medical Device Regulation framework coincide with budgetary constraints in public health systems, compelling manufacturers to demonstrate cost-effectiveness and durability. Emerging economies in the Middle East and Africa present untapped potential, incentivizing joint ventures and local manufacturing partnerships. Meanwhile, Asia-Pacific markets are characterized by expanding patient populations, rising incidences of degenerative spine conditions, and increasing government spending on healthcare infrastructure. Regional stakeholders are rapidly adopting minimally invasive techniques, driving demand for specialized cages, pedicle screws, and surface-engineered biomaterials compatible with accelerated recovery protocols.

Strategic Positioning of Leading Industry Players

The competitive landscape is anchored by established medtech giants and rapidly evolving specialized innovators. Leading participants include the technology-driven portfolio of Stryker, renowned for its additive manufacturing capabilities; Medtronic’s extensive fusion and dynamic stabilization offerings; Zimmer Biomet’s focus on custom interbody solutions; DePuy Synthes’ legacy in instrumentation amalgamated with emerging biomaterial chemistries; and NuVasive’s pioneering work in minimally invasive robotics-enhanced navigation. Beyond these incumbents, a cohort of agile specialists is introducing niche innovations in bioresorbable polymer blends, antimicrobial coatings, and patient-matched implant geometries.

Strategic initiatives among these organizations center on mergers and acquisitions to secure proprietary material platforms, in-licensing agreements to expand regenerative medicine portfolios, and collaborative R&D alliances with academic institutions. Capital allocation is increasingly directed toward clinical evidence generation, digital surgery integration, and manufacturing scale-up of next-generation composites. Ultimately, the ability to synergize deep clinical insights with advanced material technologies, while navigating evolving regulatory and tariff landscapes, will delineate the leadership quadrant in the years ahead.

Strategic Imperatives for Industry Leadership

Industry participants must prioritize robust research and development pipelines that emphasize novel biomaterials with superior biocompatibility, enhanced mechanical properties, and controlled degradation profiles. Cultivating strategic partnerships with upstream raw material innovators and downstream clinical networks will accelerate product development cycles and streamline reimbursement pathways. To fortify supply chains against tariff-induced disruptions, companies should diversify sourcing by establishing regional fabrication hubs and entering long-term procurement agreements with multiple suppliers.

Simultaneously, decision-makers must champion value-based care models by generating real-world evidence and economic analyses that underscore long-term cost savings and improved patient quality of life. Expanding footprint in emerging economies requires tailored market access strategies that reconcile local regulatory requirements with scalable commercialization frameworks. Finally, embracing digital health adjuncts-such as intraoperative mapping technologies and postoperative monitoring platforms-will not only differentiate product offerings but also deliver comprehensive solutions that resonate with payers, providers, and patients.

Rigorous Methodology Ensuring Unbiased Market Insights

This report synthesizes insights derived from a two-fold methodology encompassing primary and secondary research. Primary data were collected through structured interviews with over 50 orthopedic surgeons, hospital procurement directors, senior R&D executives, and medical device regulators, complemented by surveys of clinical trial coordinators. Secondary research involved rigorous analysis of peer-reviewed journals, regulatory filings, company annual reports, and proprietary databases to validate market dynamics and technology trends.

Quantitative data underwent triangulation against multiple sources to ensure accuracy and reliability, while qualitative findings were subjected to thematic analysis to identify emergent patterns in product innovation, patient outcomes, and reimbursement landscapes. Competitive intelligence was further enriched through patent landscaping, pipeline assessments, and benchmarking of manufacturing capacities. This multifaceted approach guarantees an unbiased, comprehensive view of the biomaterials for spinal implants market, empowering stakeholders with actionable intelligence grounded in robust empirical evidence.

Harnessing Innovation to Drive Sustainable Growth

Innovation in biomaterials is reshaping the spinal implant industry, offering new paradigms in patient care and commercial opportunity. From additive manufacturing breakthroughs that tailor implant architectures to region-specific regulatory and tariff considerations, stakeholders face a complex environment that demands agility and strategic foresight. Segmentation analyses elucidate the varied growth prospects across product categories, material chemistries, clinical applications, and care-delivery channels, while regional assessments highlight the divergent forces at play in the Americas, Europe Middle East & Africa, and Asia-Pacific.

Leading companies are consolidating market positions through targeted acquisitions and R&D collaborations, underscoring the premium placed on technology differentiation and clinical validation. To maintain competitive advantage, industry leaders must invest in advanced material research, refine supply chain resilience, and generate robust evidence portfolios that demonstrate both clinical efficacy and economic value. The convergence of these factors will catalyze sustained growth in the global spinal implant market, unlocking enhanced outcomes for patients and measurable value for healthcare systems.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Disc Replacement Devices
      • Fixed Bearing
      • Mobile Bearing
    • Interbody Cages
      • Composite Cages
      • PEEK Cages
      • Titanium Cages
    • Pedicle Screws
      • Monoaxial
      • Polyaxial
    • Rods And Plates
      • Precontoured Rods
      • Straight Rods
    • Spinal Fusion Devices
  • Material Type
    • Alumina
    • Calcium Phosphate
    • Carbon Fiber Reinforced
    • Cobalt Chromium Alloys
    • Peek
    • Polymer Matrix Composites
    • Stainless Steel
    • Titanium And Titanium Alloys
    • Uhmwpe
    • Zirconia
  • Application
    • Degenerative Disc Disease
    • Spinal Deformities
      • Kyphosis
      • Scoliosis
    • Trauma
      • Dislocations
      • Fractures
    • Tumors
  • End User
    • Ambulatory Surgery Centers
    • Hospitals
      • Government Hospitals
      • Private Hospitals
    • Orthopedic Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Globus Medical, Inc.
  • Orthofix Medical Inc.
  • Baxter International Inc.
  • SeaSpine Holdings Corporation
  • RTI Surgical, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biomaterials in Spinal Implants Market, by Product Type
8.1. Introduction
8.2. Disc Replacement Devices
8.2.1. Fixed Bearing
8.2.2. Mobile Bearing
8.3. Interbody Cages
8.3.1. Composite Cages
8.3.2. PEEK Cages
8.3.3. Titanium Cages
8.4. Pedicle Screws
8.4.1. Monoaxial
8.4.2. Polyaxial
8.5. Rods And Plates
8.5.1. Precontoured Rods
8.5.2. Straight Rods
8.6. Spinal Fusion Devices
9. Biomaterials in Spinal Implants Market, by Material Type
9.1. Introduction
9.2. Alumina
9.3. Calcium Phosphate
9.4. Carbon Fiber Reinforced
9.5. Cobalt Chromium Alloys
9.6. Peek
9.7. Polymer Matrix Composites
9.8. Stainless Steel
9.9. Titanium And Titanium Alloys
9.10. Uhmwpe
9.11. Zirconia
10. Biomaterials in Spinal Implants Market, by Application
10.1. Introduction
10.2. Degenerative Disc Disease
10.3. Spinal Deformities
10.3.1. Kyphosis
10.3.2. Scoliosis
10.4. Trauma
10.4.1. Dislocations
10.4.2. Fractures
10.5. Tumors
11. Biomaterials in Spinal Implants Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.3.1. Government Hospitals
11.3.2. Private Hospitals
11.4. Orthopedic Clinics
12. Americas Biomaterials in Spinal Implants Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biomaterials in Spinal Implants Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biomaterials in Spinal Implants Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Johnson & Johnson
15.3.3. Stryker Corporation
15.3.4. Zimmer Biomet Holdings, Inc.
15.3.5. NuVasive, Inc.
15.3.6. Globus Medical, Inc.
15.3.7. Orthofix Medical Inc.
15.3.8. Baxter International Inc.
15.3.9. SeaSpine Holdings Corporation
15.3.10. RTI Surgical, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOMATERIALS IN SPINAL IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIOMATERIALS IN SPINAL IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOMATERIALS IN SPINAL IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOMATERIALS IN SPINAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOMATERIALS IN SPINAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOMATERIALS IN SPINAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FIXED BEARING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MOBILE BEARING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COMPOSITE CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEEK CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TITANIUM CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MONOAXIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYAXIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRECONTOURED RODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STRAIGHT RODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ALUMINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CARBON FIBER REINFORCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COBALT CHROMIUM ALLOYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEEK, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYMER MATRIX COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TITANIUM AND TITANIUM ALLOYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY UHMWPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DEGENERATIVE DISC DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY KYPHOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SCOLIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISLOCATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 147. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 158. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 160. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 178. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 180. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 181. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 182. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 183. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 186. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 187. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 189. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 191. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 192. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 193. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 194. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 197. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 235. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 237. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 238. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 239. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 241. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 242. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. DENMARK BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 257. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 258. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 259. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 260. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 261. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 263. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 264. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. QATAR BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 266. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 268. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 274. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 275. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. FINLAND BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL DEFORMITIES, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 299. EGYPT BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. EGYPT BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 301. EGYPT BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY INTERBODY CAGES, 2018-2030 (USD MILLION)
TABLE 302. EGYPT BIOMATERIALS I

Companies Mentioned

The companies profiled in this Biomaterials in Spinal Implants market report include:
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Globus Medical, Inc.
  • Orthofix Medical Inc.
  • Baxter International Inc.
  • SeaSpine Holdings Corporation
  • RTI Surgical, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Orthopedic Implants Market Size, Share & Trends Analysis Report By Product (Lower Extremity Implants, Spinal Implants), By Material (Metallic Material, Ceramic Biomaterials), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Orthopedic Implants Market Size, Share & Trends Analysis Report By Product (Lower Extremity Implants, Spinal Implants), By Material (Metallic Material, Ceramic Biomaterials), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Spinal Implants Market by Product Type, Application, End User, Implant Material, Sales Channel - Global Forecast to 2030 - Product Image

Spinal Implants Market by Product Type, Application, End User, Implant Material, Sales Channel - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Spinal Implants & Surgery Devices Market by Type Of Implant, Material Used, End User, Application, Surgery Type, Product, Age Group, Growth Factors and Bone Grafts, Technology, Surgical Approach - Global Forecast to 2030 - Product Image

Spinal Implants & Surgery Devices Market by Type Of Implant, Material Used, End User, Application, Surgery Type, Product, Age Group, Growth Factors and Bone Grafts, Technology, Surgical Approach - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Spinal Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Spinal Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Spinal Implants and Surgery Devices Market Report by Product, Type of Surgery, End User, and Region 2025-2033 - Product Image

Spinal Implants and Surgery Devices Market Report by Product, Type of Surgery, End User, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.